You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0887 Pharmacokinetics, pharmacodynamics, and tolerability of verinurad (RDEA3170), a selective uric acid reabsorption inhibitor, in healthy japanese male subjects

Article metrics

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Crystal diseases, metabolic bone diseases and bone diseases other than osteoporosis
AB0887 Pharmacokinetics, pharmacodynamics, and tolerability of verinurad (RDEA3170), a selective uric acid reabsorption inhibitor, in healthy japanese male subjects
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to August 2024

AbstractFullPdf
Jun 2017400
Jul 2017400
Aug 20174003
Sep 20171800
Oct 20172402
Nov 2017600
Dec 20171400
Jan 20181403
Feb 20181600
Mar 20182803
Apr 20181000
May 20181200
Jun 20181600
Jul 2018800
Aug 20181600
Sep 2018602
Oct 2018800
Dec 20181402
Jan 2019400
Feb 2019400
Mar 2019203
Apr 2019605
May 2019202
Jun 2019402
Jul 2019602
Aug 20191203
Sep 2019200
Oct 2019603
Nov 2019001
Dec 2019402
Jan 2020200
Feb 2020001
Mar 2020401
Apr 2020001
Jun 2020402
Jul 20201003
Aug 20201803
Sep 20201800
Oct 20201802
Nov 20201200
Dec 2020801
Jan 2021203
Mar 2021401
Apr 2021601
May 2021403
Jul 2021001
Aug 2021004
Sep 2021003
Oct 20216015
Nov 20210013
Dec 2021601
Jan 2022600
Feb 2022402
Mar 2022001
Apr 2022200
May 20221208
Jun 2022803
Jul 2022600
Aug 2022802
Sep 2022208
Oct 2022203
Nov 2022606
Dec 2022400
Jan 2023201
Feb 2023200
Mar 20231400
Apr 2023002
May 2023003
Jun 2023001
Jul 2023604
Sep 2023002
Nov 2023802
Dec 2023800
Jan 2024400
Feb 2024400
Mar 2024801
Apr 2024605
May 2024400
Jun 2024400
Jul 2024400
Aug 2024200
Total5680151